Discussion on the Focus of On-site Inspection of Clinical Trials of Lung Cancer
Targeted Therapy and Immunotherapy Drugs / 中国肺癌杂志
Chinese Journal of Lung Cancer
;
(12): 506-510, 2022.
Article
Dans Chinois
| WPRIM
| ID: wpr-939739
ABSTRACT
As lung cancer targeted therapy and immunotherapy drugs are the current hot spot in the research and development area of new anti-tumor drugs, the amount of clinical trial in this area is increasing year by year. On the basis of combing the on-site inspections of drug registration clinical trials from 2019 to 2021, combined with the characteristics of lung cancer targeted therapy and immunotherapy drugs, this paper discusses the focus of on-site inspection of clinical trials of such drugs, and puts forward suggestions for the compliant implementation of lung cancer clinical trials.
.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Thérapie moléculaire ciblée
/
Facteurs immunologiques
/
Immunothérapie
/
Tumeurs du poumon
/
Antinéoplasiques
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Chinese Journal of Lung Cancer
Année:
2022
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS